Atrial fibrillation (AF) is the most common cardiac arrhythmia, the prevalence of which is
increasing with the aging of the population. Because of its clinical importance and the lack of …

Atrial fibrillation, the most common arrhythmia, is frequently disabling and drug resistant.
Non-pharmacological approaches including surgery and catheter-based ablation have been …

Therapy of atrial fibrillation remains difficult in many patients. There is increasing awareness
that antiarrhythmic drug therapy instituted to maintain sinus rhythm after successful cardio …

Despite recent advances in our understanding of the mechanism of atrial fibrillation (AF),
effective treatment remains difficult in many patients. Pharmacotherapy remains the …

Pharmacologic treatment continues to be the mainstay of therapy in patients with atrial
fibrillation (AF). Over the past few years, considerable progress has been made in …

The morbidity and mortality associated with atrial fibrillation (AF), the most frequent cardiac
arrhythmia, remain substantial. The efficacy and safety of current antiarrhythmic drugs …

Atrial fibrillation (AF) is a common cardiac arrhythmia which is particularly prevalent among
the elderly. In patients with AF of recent onset, restoration of sinus rhythm may be feasible …

Atrial fibrillation (AF) is a progressive disease that continues to inflict a heavy burden on
health care systems and patients. AF portends an increased all-cause mortality, long-term …

Various nonpharmacologic interventions are available for patients with atrial fibrillation (AF)
who are refractory to standard drug therapy. Atrioventricular junctional ablation and …

Atrial fibrillation (AF) remains a difficult management problem. The restoration and
maintenance of sinus rhythm—rhythm control therapy—can markedly improve symptoms …